ClinicalTrials.Veeva

Menu

From Uncomplicated Alcoholism to Korsakoff's Syndrome (ALCOBRAIN)

C

Caen University Hospital

Status

Unknown

Conditions

Alcoholism
Alcohol Amnestic Disorder

Treatments

Biological: blood draw
Other: Brain imaging examination
Behavioral: Neuropsychological testing
Genetic: genetic testing

Study type

Interventional

Funder types

Other

Identifiers

NCT01455207
11-050
2011-A00495-36

Details and patient eligibility

About

This research project aims to identify factors that contribute to the heterogeneity observed in neuroradiological and neuropsychological signs of chronic alcoholism. The investigators overarching hypothesis is that the heterogeneity of alcoholic consequences on brain structure and metabolism, and cognition is mainly related to individual differences in pattern of alcohol use, gene pool, nutritional status and history of withdrawal symptoms.

Enrollment

220 estimated patients

Sex

All

Ages

21 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Completed at least 8 years of education (primary school equivalent)
  • Age-normal corrected hearing and visual acuity

Exclusion criteria

  • documented loss of consciousness of over 30 minutes, documented compound skull fracture, or clear neurological sequelae of head trauma
  • history of medical or neurological illness or trauma potentially affecting the CNS, e.g., stroke, multiple sclerosis, epilepsy, psychosurgery, insulin coma.
  • active tuberculosis or history of or any malignancy requiring chemotherapy
  • history of schizophrenia or bipolar disorder
  • metal implantation (e.g., pacemakers) or other factors that preclude MRI scanning for subjects selected for the neuroimaging examination
  • meet DSM-IV criteria for current (past 3 months) other Substance Abuse
  • met DSM-IV criteria for other Substance Dependence
  • Have used other substances more than 5 times in the past month

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Factorial Assignment

Masking

None (Open label)

220 participants in 3 patient groups

alcoholic patients
Other group
Treatment:
Genetic: genetic testing
Biological: blood draw
Behavioral: Neuropsychological testing
Other: Brain imaging examination
korsakoff patients
Other group
Treatment:
Genetic: genetic testing
Biological: blood draw
Behavioral: Neuropsychological testing
Other: Brain imaging examination
healthy controls
Other group
Treatment:
Genetic: genetic testing
Biological: blood draw
Behavioral: Neuropsychological testing
Other: Brain imaging examination

Trial contacts and locations

1

Loading...

Central trial contact

Julien Chavant, MA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems